Prestige Consumer Healthcare Inc. (PBH) Stock Analysis

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis — AI Research | MarketCI

PBH

Market Closed

Prestige Consumer Healthcare Inc.

NYSEHealthcare Medical - Distribution

890 employees

CEO: Ronald Lombardi

Founded: 2005

$49.66

+$0.00(+NaN%)

Market Cap

2.35B

Beta

0.35

52W Range

N/A

Dividend Yield

0.96%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

PBH Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for PBH built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Buy

Pass %

71.43%

Score

5/7

Fair Value Estimate

Cash flow analysis • Multiple methods

$316.82

AI Price Target

Machine learning • Price prediction

$46.95

Market Sentiment

News & social media analysis

0.00

Value Investor Price

Classic value analysis

$58.67

Financial Health

Bankruptcy risk assessment

2.19

Quality Score

Financial strength rating

5.00

AI Investment Grade

Deep analysis of filings & news

68.00

Key Investment Highlights

Important factors affecting PBH investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

73.68% Good

Conditions Met

28.00/38.00

Due Diligence Score

73.68%

Due Diligence Conditions

Investment analysis conditions and results


	Fail
	Pass
	Pass
	Pass
	Pass
	Pass

Showing 1 to 6 of 46 conditions